News
Nicotine is one of the hardest addictions to kick; one of the reasons many say you shouldn’t start smoking in the first place ...
India has banned e-cigarettes to protect youth from harm, despite misconceptions about vaping's safety and effectiveness for ...
The U.S. Food and Drug Administration recently authorized the marketing of 20 nicotine pouch products under the Zyn brand, including flavors like Wintergreen and the "unflavored" Chill.
According to a 2023 explainer in The Guardian, there is between 8mg and 20mg of nicotine in a cigarette. But only a small amount, around 1-2mg, of that is inhaled. Nicotine pouches. Brand: Peak- ...
MG Motor India showcased its latest global models at the Bharat Mobility Global Expo 2025, including the Majestor, M9, and Cyberster. Now, reports suggest that the MG S5 EV will soon replace the ZS EV ...
This is the next-generation MG 4… or is it an MG 3 EV, or an MG E5? Car News China has shared these images from a Chinese Ministry of Industry and Information Technology (MIIT) filing. These filings ...
MG has played an important role at the entry-level end of Australia's new car market. Compact cars like the MG ZS SUV and MG 3 city car were often lauded for their affordable price and value-for ...
In the years since British Leyland stopped importing the MGB to the United States in 1980, MG has endured more changes of ownership than have some of its cars. In the hands of current Chinese ...
JSW MG Motor India has launched the MG Comet EV 2025. While the electric car can be bought at a starting price of Rs 7 lakh (ex-showroom), the battery-as-a-service (BaaS) model allows you to have it ...
Your browser does not support the audio element. The MG Comet line-up has been updated for 2025 with a few feature upgrades, except for the entry-level Executive ...
Sweet flavoured nicotine pouches are more likely to be consumed in high quantities by users than other varieties, researchers have warned. The number of adults who have ever used nicotine pouches ...
Genmab (GMAB) announced updated data from cohort B1 of the Phase 1/2 RAINFOL-01 study of rinatabart sesutecan, an investigational folate receptor-alpha-targeted, TOPO1 antibody-drug conjugate that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results